中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | (+)-2-hydroxy-N-methylmorphinan-6-one | 84375-09-7 | C17H21NO2 | 271.359 |
—— | (+/-)-2-hydroxymorphinan-6-one | 84375-07-5 | C16H19NO2 | 257.332 |
—— | (+)-2-<(1-phenyl-1H-tetrazol-5-yl)oxy>-N-methylmorphinan-6-one | 84471-50-1 | C24H25N5O2 | 415.495 |
—— | (+/-)-2-<(1-phenyl-1H-tetrazol-5-yl)oxy> morphinan-6-one | 95712-63-3 | C23H23N5O2 | 401.468 |
Bischler–Napieralski cyclization of the known phenylacetamide 1, followed by selective ether cleavage of the 3,4-dihydroisoquinoline 2 and sodium borohydride reduction, afforded the tetrahydroisoquinoline 4. Optical resolution of 4 with tartaric acid gave the optical isomers 4a,b, which were converted into the 6-ketomorphinans 9a,b and their O-methyl ethers 10a,b by the following reaction sequence: Birch reduction, N-formylation of the dihydro bases, Grewe cyclization, removal of the N-formyl protecting groups, reductive N-methylation, and O-methylation. The 2-deoxy congeners 12a,b were obtained from 9a,b by phenyltetrazolylation, and catalytic removal of the heterocyclic etherfunction. The (−)-enantiomer 12a obtained by this synthesis was identical with material prepared from natural morphine, and exhibited the high antinociceptive potency already reported.